Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-16

Clinical Trial Update: Adjunctive Glycine for Obsessive Compulsive Disorder [NA]

View source ↗

Summary

A completed clinical trial evaluated adjunctive glycine as an add-on treatment for obsessive-compulsive disorder. The study was conducted under the Nathan Kline…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glycine (glycine)

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Obsessive Compulsive Disorder | NA | Status: COMPLETED